BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Clinical trial NCT06794008 · RECRUITING

Trial details

NCT number: NCT06794008
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Inflammatory Myopathy Systemic Sclerosis (SSc)ANCA-associated Vasculitis IgG4-Related Diseases Antiphospholipid Syndrome Acquired Thrombotic Thrombocytopenic Purpura Behcet Disease Sjogren Syndrome

Start date: 2024-12-26
Primary completion: 2027-12-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.